Alexion Pharmaceuticals
Data breach claim reported November 10, 2026
| Data Breach Report | |||
|---|---|---|---|
| Victim | alexion.com | ||
| Claimed By | Vortex | ||
| Date Discovered | Nov 10, 2026 | ||
| Description | Alexion Pharmaceuticals, Inc. is a biopharmaceutical company based in USA (Massachusetts), a rare disease unit of AstraZeneca that develops and markets complement-inhibitor medicines for rare, immune-mediated diseases. | ||
| Leak Size | 2.13TB |
Breach claims on this page are published by threat actors and haven't been verified by Breachsense.
Credential Exposure for alexion.com
We've indexed 492 @alexion.com accounts from external breaches, plus 40 credentials for alexion.com itself.
Last checked Nov 10, 2026
| @alexion.com addresses from external breaches | |
|---|---|
| Third-party breaches | 449 accounts · across 67 breaches · 302 with a plaintext password · most recent Dec 29, 2024 |
| Combo lists | 103 accounts · most recent Nov 9, 2026 |
| Passwords for alexion.com accounts | |
|---|---|
| Combo lists | 33 logins · most recent Nov 8, 2026 |
| Infostealer logs | 16 logins · 6 infected devices · most recent Nov 6, 2026 |
Logins may belong to customers or to staff, and the data doesn't say which. None of this is necessarily connected to the ransomware attack above.
Is your organization next?
Check if your company's credentials have been exposed in this or other data breaches.
Continuous dark web monitoring alerts you when we find leaked credentials or session tokens for your company.